The case against METs
One of the most fundamental arguments against METs is that surprisingly there is no clear-cut evidence in favour of cardiac arrest team systems, which have served as the model on which most METs have been designed. The more detailed evidence against METs comes from a rigorous analysis of the studies that on the face of it purported to show benefits. The question being raised is simply this: are the data in such studies flawed to the extent that they cannot be trusted. For example, some studies involved the comparison of hospitals using the MET system with others that didn’t. Clearly differences between the basic case composition of the different hospitals could bias the results. A priori, the use of studies in the same hospital before and after the introduction of METs should minimise this problem, but even here problems still exist, such as seasonal variations, differences in case mix and general changes with time of the overall health care provision.
Accepting the limitations of such “before and after studies”, two studies have shown that there is no demonstrable benefits to the introduction of METs. In a UK study, Kenward et al [3] looked at the effect of the introduction of a MET on the incidence of cardiac arrest and in-hospital death. The study was carried out over a period of one year before and one year after the introduction of MET. For both outcome parameters, no benefit was shown for the existence of METs.
The MERIT study (Medical Early Response. Intervention and Therapy) is the largest and most robust study of METS and involved 23 hospitals in a prospective cluster-randomised trial [4], with the primary outcome being the composite of unexpected death, cardiac arrest and unplanned ICU admission. The studies were designed such that for each hospital there was a baseline period of two months prior to the introduction of METs in the test group of hospitals. Of course, in the control group of hospitals, no METs were set up after the baseline period. It was found that a significant improvement in the outcomes between the baseline period and test only occurred in the control group of hospitals (i.e. those with no METs)! Direct comparison of the test and control hospitals showed no statistically significant improvement in those hospitals using METs. Various theories have been advanced to explain the apparent lack of efficacy in the MERIT studies. One is that the triggers used to call the MET [Table 1} were not specific or sensitive enough. Likewise the use of a composite outcome criterion of unexpected death, cardiac arrest and unplanned ICU admission may have been inappropriate. Other explanations could be inappropriate staffing or inappropriate or inadequate interventions. However until clear evidence for the benefits of METs is presented, the case for their implementation remains seriously flawed.
References
1. Price RJ and Cuthbertson BH. Should hosiptals have a medical emergency team? in Controversies in Intensive Care medicine ed by Kuhlen R, Moreno R, Ranieri M and Rhodes A, pub by Medizinisch Wissenshftliche Verlagsgesellschaft 2008
2. DeVita MA et al. Findings of the first consensus conference on medical emergency teams Crit Care Med 2006; 34: 2463.
3. Kenward G et al. Evaluation of a Medical Emergency Team one yearafter implementation. Resuscitation:; 2004: 61: 257.
4. Hillman K et al. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet 2005; 365:2091.